Standout Papers

Lifetime risk of atrial fibrillation according to optimal, borderline, or elevated levels of risk factor... 2018 2026 2020 2023 226
  1. Lifetime risk of atrial fibrillation according to optimal, borderline, or elevated levels of risk factors: cohort study based on longitudinal data from the Framingham Heart Study (2018)
    Laila Stærk, Biqi Wang et al. BMJ

Immediate Impact

3 from Science/Nature 80 standout
Sub-graph 1 of 19

Citing Papers

Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation
2025 Standout
Applied body-fluid analysis by wearable devices
2024 StandoutNature
3 intermediate papers

Works of Lu‐Chen Weng being referenced

Predictors of oral anticoagulant non-prescription in patients with atrial fibrillation and elevated stroke risk
2018
Stroke as the Initial Manifestation of Atrial Fibrillation
2017

Author Peers

Author Last Decade Papers Cites
Lu‐Chen Weng 1123 160 173 226 213 44 1.8k
Larry E. Fields 1311 102 165 377 169 30 2.6k
Ronald T. Gansevoort 581 189 124 255 235 37 1.9k
Daniele Longo 396 109 166 208 210 47 1.9k
Parul Tandon 1391 100 409 343 180 46 2.2k
Enrica Golia 875 53 214 212 285 31 1.7k
Paul N. Jensen 1235 102 287 523 283 48 2.3k
Darae Ko 1518 85 138 442 240 58 2.2k
Francesco Natale 794 55 341 197 236 62 1.7k
Jeetesh V. Patel 886 53 299 295 307 52 2.0k
Danielle Enserro 915 50 209 174 154 44 1.6k

All Works

Loading papers...

Rankless by CCL
2026